✦ LIBER ✦

Angiotensin II receptor antagonists - antihypertensive agents

✍ Scribed by Burnier, M; Brunner, HR

Book ID: 121242676
Publisher: Informa plc
Year: 1997
Tongue: English
Weight: 242 KB
Volume: 6
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.6.5.489

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in antihypertensive therapy: No

Advances in antihypertensive therapy: Non-peptide angiotensin II receptor antagonists as potent therapeutic agents

✍ Julian Smith; Amal Wahhab; John Hondrelis; Renee Ganter; Diana Moore; John M. Ma 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 301 KB

The development of drugs that selectively block angiotensin receptors has resulted largely from a process of trialand-error medicinal chemistry on an early lead. The new generation of angiotensin antagonists or angiotensin mimetics are essentially devoid of side effects and are set to replace the an

Angiotensin II Receptor Antagonists

✍ Messerli, F H 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Angiotensin II receptor antagonists

✍ M Burnier; HR Brunner 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 118 KB

Losartan/angiotensin II antagonists have

Losartan/angiotensin II antagonists have greater persistence than other antihypertensive agents/classes

✍ Paul R. Conlin; James Fox; William C. Gerth; Stephen J. Boccuzzi 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 33 KB

Nonpeptide angiotensin II receptor antag

Nonpeptide angiotensin II receptor antagonists

✍ Pieter B.M.W.M. Timmermans; Pancras C. Wong; Andrew T. Chiu; William F. Herblin 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 940 KB

Angiotensin receptor antagonists–a new c

Angiotensin receptor antagonists–a new class of antihypertensive drug

✍ C. R. Gibbs; R. E. Femer; D. G. Beevers 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB